Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis (Q33598247)

28 July 2017

Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis (English)

1 reference

cost-effectiveness analysis

28 July 2017

1 reference

1 reference

Clostridium difficile

object named as

Clostridium difficile

1 reference

Gauree G Konijeti

1

1 reference

28 July 2017

Jenny Sauk

2

1 reference

28 July 2017

Mark G Shrime

3

1 reference

28 July 2017

Meera Gupta

4

1 reference

28 July 2017

Ashwin N Ananthakrishnan

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

31 March 2014

1 reference

Clinical Infectious Diseases

28 July 2017

1 reference

28 July 2017

58

1 reference

28 July 2017

11

1 reference

28 July 2017

1507-1514

1 reference

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Can we identify patients at high risk of recurrent Clostridium difficile infection?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Consequences of Clostridium difficile infection: understanding the healthcare burden

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Burden of gastrointestinal disease in the United States: 2012 update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Hospital-acquired Clostridium difficile infection: determinants for severe disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Treating Clostridium difficile infection with fecal microbiota transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

The economic burden of Clostridium difficile

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Predictors of mortality after colectomy for fulminant Clostridium difficile colitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

One thousand health-related quality-of-life estimates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017891

Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology

21 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU128

Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients

21 January 2018

1 reference

12 December 2020

Toward consistency in cost-utility analyses: using national measures to create condition-specific values

1 reference

12 December 2020

A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis

1 reference

12 December 2020

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

1 reference

12 December 2020

An evaluation of utility measurement in Crohn's disease

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIU128

1 reference

28 July 2017

1 reference

28 July 2017

1 reference